These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

884 related articles for article (PubMed ID: 33558944)

  • 1. [Treatment of sepsis-induced coagulopathy : Results of a Germany-wide survey in intensive care units].
    Schmoch T; Brenner T; Becker-Pennrich A; Hinske LC; Weigand MA; Briegel J; Möhnle P;
    Anaesthesist; 2021 Aug; 70(8):662-670. PubMed ID: 33558944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
    Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
    Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Practice of pharmaceutical thrombosis prophylaxis and anticoagulation in patients with sepsis and pre-existing anticoagulation or heparin-induced type II thrombocytopenia-Results of a nationwide survey in German intensive care units].
    Schmoch T; Brenner T; Becker-Pennrich A; Hinske LC; Weigand MA; Briegel J; Möhnle P;
    Anaesthesist; 2022 Mar; 71(3):193-200. PubMed ID: 34351433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
    Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pragmatic Recommendations for the Management of Anticoagulation and Venous Thrombotic Disease for Hospitalized Patients with COVID-19 in Low- and Middle-Income Countries.
    Ahmed HY; Papali A; Haile T; Shrestha GS; Schultz MJ; Lundeg G; Akrami KM;
    Am J Trop Med Hyg; 2021 Jan; 104(3_Suppl):99-109. PubMed ID: 33432908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unfractionated heparin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in trauma.
    Jacobs BN; Cain-Nielsen AH; Jakubus JL; Mikhail JN; Fath JJ; Regenbogen SE; Hemmila MR
    J Trauma Acute Care Surg; 2017 Jul; 83(1):151-158. PubMed ID: 28426561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of unfractionated heparin versus low-molecular-weight heparin and fondaparinux for pharmacologic venous thromboembolic prophylaxis in critically ill patients with cancer.
    Van Matre ET; Reynolds PM; MacLaren R; Mueller SW; Wright GC; Moss M; Burnham EL; Ho PM; Vandivier RW; Kiser TH
    J Thromb Haemost; 2018 Dec; 16(12):2492-2500. PubMed ID: 30347498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulation for the initial treatment of venous thromboembolism in people with cancer.
    Hakoum MB; Kahale LA; Tsolakian IG; Matar CF; Yosuico VE; Terrenato I; Sperati F; Barba M; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD006649. PubMed ID: 29363105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial.
    Spyropoulos AC; Goldin M; Giannis D; Diab W; Wang J; Khanijo S; Mignatti A; Gianos E; Cohen M; Sharifova G; Lund JM; Tafur A; Lewis PA; Cohoon KP; Rahman H; Sison CP; Lesser ML; Ochani K; Agrawal N; Hsia J; Anderson VE; Bonaca M; Halperin JL; Weitz JI;
    JAMA Intern Med; 2021 Dec; 181(12):1612-1620. PubMed ID: 34617959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of venous thromboembolism in critically ill medical patients: a Franco-Canadian cross-sectional study.
    Lacherade JC; Cook D; Heyland D; Chrusch C; Brochard L; Brun-Buisson C;
    J Crit Care; 2003 Dec; 18(4):228-37. PubMed ID: 14691896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.
    Robertson L; Strachan J
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006771. PubMed ID: 28195640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicentre controlled pre-post trial of an implementation science intervention to improve venous thromboembolism prophylaxis in critically ill patients.
    Stelfox HT; Brundin-Mather R; Soo A; Parsons Leigh J; Niven DJ; Fiest KM; Doig CJ; Zuege DJ; Kushner B; Clement F; Straus SE; Cook DJ; Bagshaw SM; Sauro KM
    Intensive Care Med; 2019 Feb; 45(2):211-222. PubMed ID: 30707246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboprophylaxis in adult and paediatric burn patients: A survey of practice in the United Kingdom.
    Vermaak PV; D'Asta F; Provins J; Farr M; Wilson YT
    Burns; 2019 Sep; 45(6):1379-1385. PubMed ID: 31079961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of thromboembolism in German intensive care units : Results of a nationwide survey].
    Hilbert P; Teumer P; Stuttmann R
    Anaesthesist; 2008 Mar; 57(3):242-50. PubMed ID: 18256805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism.
    Robertson L; Jones LE
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD001100. PubMed ID: 28182249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low molecular weight heparin for prevention of central venous catheter-related thrombosis in children.
    Pelland-Marcotte MC; Amiri N; Avila ML; Brandão LR
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD005982. PubMed ID: 32557627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enoxaparin may be associated with lower rates of mortality than unfractionated heparin in neurocritical and surgical patients.
    Samuel S; To C; Ling Y; Zhang K; Jiang X; Bernstam EV
    J Thromb Thrombolysis; 2023 Apr; 55(3):439-448. PubMed ID: 36624202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.
    Akl EA; Kahale L; Neumann I; Barba M; Sperati F; Terrenato I; Muti P; Schünemann H
    Cochrane Database Syst Rev; 2014 Jun; (6):CD006649. PubMed ID: 24945634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness of low-molecular-weight heparin versus unfractionated heparin for thromboembolism prophylaxis for medical patients.
    Rothberg MB; Pekow PS; Lahti M; Lindenauer PK
    J Hosp Med; 2012; 7(6):457-63. PubMed ID: 22473716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.